Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 23 Jun 2009 Actual patient number changed from 168 to 177 as reported by ClinicalTrials.gov.
- 23 Jun 2009 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History